How The OceanOmics Centre is Using the Maxwell RSC to Scale eDNA Biodiversity Monitoring

This blog is written by guest blogger Ben Rushton, Application Specialist/Territory Manager at Promega Australia.

When you’re monitoring marine biodiversity at scale, every drop of seawater tells a story. At Minderoo OceanOmics Centre at the University of Western Australia, scientists are uncovering that story through environmental DNA (eDNA)โ€”and automation is helping them listen more clearly.

Laura Missen, a Scientific Officer at OceanOmics Centre, shares how automating their DNA extraction workflow with the Maxwellยฎ RSC 48 system has transformed how they gather and interpret data from marine ecosystems.

(Image credit: Giacomo d’Orlando / Ronin_Lab)
Continue reading “How The OceanOmics Centre is Using the Maxwell RSC to Scale eDNA Biodiversity Monitoring”

How Thalidomide and Molecular Glues Are Rede๏ฌning Drug Discovery

Targeted protein degradation (TPD) is a strategy used to selectively remove proteins from cells, rather than simply blocking their activity. Traditional small-molecule drugs work by binding to a protein and inhibiting its function, leaving the protein intact. In contrast, TPD harnesses the cell waste-disposal systemโ€”in particular, the ubiquitin-proteasome pathwayโ€”to tag the target protein for destruction. Once tagged, the protein is chopped up and recycled by the proteasome, eliminating it from the cell.

Perhaps the best known TPD approach uses PROTACs (proteolysis-targeting chimeras), which are bifunctional molecules: one end binds the protein of interest, and the other recruits an E3 ubiquitin ligase. By bringing the protein and ligase together, the PROTAC triggers ubiquitin tagging and subsequent degradation.

How NanoBRET works image.

Molecular glues achieve the same end resultโ€”selective protein destructionโ€”in a different way. Instead of acting as a physical bridge between the protein and the E3 ligase, molecular glues bind to one protein (often the ligase) and subtly change its shape or surface properties, improving interaction with the target protein. This induced fit causes the target protein to be ubiquitinated without a large, two-part molecule like a PROTAC.

Continue reading “How Thalidomide and Molecular Glues Are Rede๏ฌning Drug Discovery”

Exploring the Relationship Between IC50 and Kd in Pharmacology

This guest blog post is written by Tian Yang, Associate Product Manager at Promega.

In the realm of chemical probe development and drug discovery, understanding the interactions between drugs/compounds and their targets is crucial. Two frequently used metrics to characterize these interactions are IC50 and Kd, which guide researchers in evaluating the potential of compounds in effecting changes in target function. IC50 offers insights into a compound’s potency by quantifying its ability to inhibit a specific biological activity. Kd provides a measure of the affinity between a ligand and its receptor, reflecting how tightly a compound binds to its target (1). Together, these parameters are instrumental in the early stages of drug development, helping to identify promising candidates by assessing a compoundsโ€™s binding characteristics and its observed efficacy.

Continue reading “Exploring the Relationship Between IC50 and Kd in Pharmacology”

Why mRNA Transfection Is Transforming Transient Expression Workflows

Transfection is a core technique in molecular biology used to introduce foreign nucleic acidsโ€”such as DNA, RNA, or small RNAs like siRNA, shRNA, and miRNAโ€”into eukaryotic cells. This enables researchers to manipulate gene expression and study cellular processes, disease mechanisms and therapeutic strategies (1).

Advances in transfection technology now support a range of nucleic acid types and cell models. Researchers can pursue transient or stable expression to achieve specific goals: knocking down transcripts, expressing proteins, or probing promoter activity in systems from immortalized lines to stem cells (1).

Continue reading “Why mRNA Transfection Is Transforming Transient Expression Workflows”

An Unexpected Culprit in Heart Disease? Meet Your Gut Microbesย 

For decades, heart diseaseโ€“particularly atherosclerosis, a condition characterized by the buildup of plaque in the artery wallsโ€“has remained the worldโ€™s top health challenge despite major medical advances. Cholesterol and high-fat diets have long shouldered the blame, but new research published in Nature uncovers an unexpected suspect: our gut microbes.ย ย 

Continue reading “An Unexpected Culprit in Heart Disease? Meet Your Gut Microbesย “

ATP-Powered Proteins Beyond Kinases โ€“ and Why Helicases Are Stealing the Spotlight

This blog was written by guest author Michael Curtin, Senior Product Manager, Small Molecule Drug Discovery.

ATP is the universal energy currency of cells, and thousands of proteins outside the kinase family โ€œspendโ€ it to move cargo, remodel nucleic acids, pump ions, or fold proteins. These ATP-hydrolyzing enzymesโ€”collectively known as ATPasesโ€”span functional classes including motor proteins, transporters, chaperones, chromatin remodelers, ligases, and, crucially for genome stability, helicases.

From DNA replication to RNA processing, helicases are essential players. DNA/RNA helicases such as MCM, XPB/XPD, WRN, and members of the DDX family sit alongside AAA+ unfoldases, ABC transporters, and V-ATPasesโ€”all drawing on ATP to power their molecular work.

Continue reading “ATP-Powered Proteins Beyond Kinases โ€“ and Why Helicases Are Stealing the Spotlight”

Matching Luciferase Reporter Assays to Your Experimental Goals

Luciferase reporter assays are highly versatile, but their true power comes when the reporter system youโ€™ve selected is well aligned with your experimental objectives. Whether you’re tracking transcriptional changes or pathway activity, assessing miRNA/siRNA regulation, or using as a readout in CRISPR-based screens, choosing a reporter and detection assay format that fit your specific research goal is critical for meaningful, reproducible results.

You may have already read about how to choose a luciferase reporter assay, but now, we will walk through how to match luciferase reporter systemsโ€”reporter types, detection chemistries, and formatsโ€”to your specific experimental needs. While luciferases like NanoLuc have applications beyond gene expression, this blog focuses on genetic reporter applications and the workflows that support them.

Continue reading “Matching Luciferase Reporter Assays to Your Experimental Goals”

HiBiT-Based NanoBRETยฎ Assay Sheds Light on GPCRโ€“Ligand Binding in Live Cells

G-protein-coupled receptors (GPCRs) are among the most important drug targets in human biology, mediating signals across nearly every physiological system. But not all GPCRs are equally easy to studyโ€”especially those that interact with peptide ligands. These ligands tend to be flexible, fast-moving, and hard to trace in live cells by standard methods. Historically, radioligand binding assays have filled this gap, offering a way to measure peptideโ€“receptor interactions with high sensitivity. However, these assays are typically performed using isolated membrane preparations or cells under non-physiological conditions, and they donโ€™t allow for real-time or kinetic measurements.

Artistic Image of Hibit Tag

Continue reading “HiBiT-Based NanoBRETยฎ Assay Sheds Light on GPCRโ€“Ligand Binding in Live Cells”

How Computational Design Can Predict the Next Viral Variantโ€”and Help Us Prepare

As SARS-CoV-2 continues to evolve, one lesson is painfully clear: immunity today may not guarantee protection tomorrow. Viruses are experts at mutating into countless variants to evade detection or neutralization by the immune system. In the race to keep up with this “immune escape”, researchers have largely focused on reactive strategiesโ€”testing vaccines against variants that already exist. But what if we could flip the script and anticipate where the virus is going next?

Thatโ€™s precisely the aim of a new study published in Immunity.ย This study introducesย EVE-Vax, a computational design platform that builds synthetic spike proteins capable of mimicking immune escape mutationsโ€”before they naturally arise.

Continue reading “How Computational Design Can Predict the Next Viral Variantโ€”and Help Us Prepare”

20 Years of Organ Transplant Testing with Maxwellยฎ Instrumentation

MacKenzie Gartner, Lead Technologist at DCi, operates a Maxwellยฎ instrument.
MacKenzie Gartner, Lead Technologist at DCi, operates a Maxwellยฎ instrument.

For twenty years, the transplant lab at Dialysis Clinic, Inc. (DCi) in Nashville, TN has depended on Maxwell instruments for their automated nucleic acid purification. In fact, the lab was the first to purchase the instrument when it debuted in 2005. Today, theyโ€™ve scaled up to three of the latest Maxwellยฎ Instruments.

โ€œTheyโ€™re great little instruments,โ€ says Christina Sholar, Clinical Supervisor at DCi. โ€œI think this is our third generation, and we still have the original in the basement. We love them.โ€

Christinaโ€™s lab runs critical tests to ensure compatibility between donors and recipients for solid organ and stem cell transplants. With precious samples and urgent demands, they need tools they can depend on for high-quality results. Their Maxwellยฎ instruments help them ensure successful downstream analysis to support important clinical decisions.

Precious Samples, Urgent Timelines

A DCi lab technician adds a sample to a cartridge before loading the Maxwellยฎ instrument.
Hailey, a technician at DCi, loads a Maxwellยฎ cartridge.

Founded in 1971 as a non-profit dialysis clinic, DCi now supports a broad spectrum of kidney health issues, including transplants. The company has also expanded its operations to support organ transplants through federally designated organ procurement organizations. Christinaโ€™s lab runs the tests to ensure compatibility between donors and recipients.   

โ€œWe cover the state of Tennessee,โ€ Christina says. โ€œWe do the typing and antibody analysis for solid organ transplants, and then we follow them post-transplant to see if theyโ€™ve developed antibodies to the donor. We also do stem cell workups and follow-ups.โ€

The lab processes 150-200 samples per week. In addition to managing the high sample throughput, the team also must be available 24/7 for urgent calls when an organ donor passes away.

โ€œWe used to average about 50 donors a month, but thatโ€™s creeping up,โ€ Christina says.

Christina says her team needs a workflow built for speed and minimal hands-on processing. With downstream assays including NGS and qPCR, they also need to trust theyโ€™ll have a high-quality DNA sample to work with. Thatโ€™s what led them to the Maxwell platform in 2005.

Instrumentation for Easy, Reliable Results  

โ€œMaxwell purifications are an easy thing to start new employees with, because they can get quality DNA very easily,โ€ says MacKenzie Gartner, Lead Technologist in Christinaโ€™s lab at DCi. โ€œTechs pick up on it very quickly, and itโ€™s something they can feel confident in doing by themselves.โ€

Twenty years ago, the lab was using manual methods to purify all their nucleic acids. Unlike MacKenzie, Christina remembers those days and admits they werenโ€™t fun. The protocols were labor-intensive, and much more prone to human error. Now, they donโ€™t even teach manual methods anymore.

The DCi lab currently operates three Maxwellยฎ instruments.
The DCi lab currently operates three Maxwellยฎ instruments.

โ€œWhen I came on nine years ago, they were teaching a manual method as backup for the Maxwell instruments, but they never got around teaching it to me because it was needed so rarely,โ€ MacKenzie says. โ€œNow itโ€™s not even in the training materials.โ€

MacKenzie works hands-on with the Maxwell instruments almost every day. The lab mainly uses the Maxwellยฎ Buffy Coat DNA Kit and Maxwellยฎ Buccal Swab DNA Kit. Buccal swabs require 20 minutes of passive pre-processing, but buffy coats can be added directly to the Maxwell cartridges. From there, the automated protocol is only 45 minutes.

โ€œItโ€™s nice that both of them can be run on the same instrument, which gives us flexibility knowing that all three instruments can be available no matter what weโ€™re doing,โ€ MacKenzie adds.

One of the lab's original Maxwellยฎ instruments, still in storage in the basement.
One of the lab’s original Maxwellยฎ instruments, still in storage in the basement.

Christina says the Maxwell instruments provide much cleaner DNA eluates than their past manual methods. This is invaluable for lab efficiency, but itโ€™s even more important with stem cell testing.

โ€œWith stem cells, they may only send one tube but want three or four different tests,โ€ she explains. โ€œWe donโ€™t have room for error โ€“ those samples are precious.โ€

โ€œWe keep the instruments pretty active,โ€ MacKenzie adds. โ€œThat room constantly has their little noises going. But theyโ€™re so dependable โ€“ they donโ€™t take much maintenance, and we can count on having one available even when we get some urgent samples from a donor.โ€

Long-Term Partnership for Success

โ€œPromega is probably our favorite company to work with, as far as support goes,โ€ Christina says. โ€œWe rarely have issues, but when we do, we get great responses very quickly.โ€

As a leader, Christina values strong relationships with her suppliers. Though the labโ€™s sales representative has changed a few times over the past two decades, she says each one has been reliable and helpful in keeping the lab operations running smoothly. The lab has also benefited from regularly scheduled preventive maintenance visits from Promega service engineers.

โ€œOverall, I just love how dependable the instruments are,โ€ Christina says. โ€œWeโ€™re using them all the time. Theyโ€™re truly our workhorses.โ€

All photos credit: DCi